Events, congresses and meetings

2025 was a year defined by double-digit growth in net sales (+12.4 %) and EBITDA (+20.9 %), further building our leadership in medical dermatology.  Our success was based on our commitment to scientific advancement and the development of impactful solutions for unmet medical needs. 

Almirall - Financial Results

At the 17th Skin Academy, global experts came together over two days to share knowledge, challenge perspectives, and advance medical dermatology — all with one common goal: improving patients’ lives.